Buy BPC157 Capsules

BPC-157 Capsules — Research-Grade Pentadecapeptide (Body Protection Compound)

BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protective gastric protein and used exclusively in laboratory research.
Preclinical literature explores its role in tissue-repair models, angiogenesis modulation, and GI and musculoskeletal investigations.
For laboratory research only; not for human or veterinary use.
(Frontiers +2 • PMC +2)

BPC-157 — Definition & Purpose

Definition: BPC-157 (sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) is a stable gastric pentadecapeptide investigated in cell and animal models for its effects on tissue healing biology and vascular remodeling.
Researchers use it to probe growth-factor signaling, inflammatory cascades, and angiogenesis within controlled protocols.
(Frontiers +1)

At-a-Glance Research Attributes

Category: Synthetic research peptide (pentadecapeptide)
Molecular Weight: ~1419.5 Da (capsule format for handling convenience)
Primary Research Focus: Tissue repair models, angiogenesis modulation, GI and tendon/ligament studies
Documentation: Batch-linked COA — COA Hub | COA Guide
Integrity: Target purity ≥ 98% (HPLC); third-party tested (link your COA PDF in gallery)
(Frontiers +1)

Research Applications

• Tissue & Ortho Models: Tendon/ligament integration, muscle injury recovery, bone and wound proxies

• GI & Mucosal: Ulcer, fistula, and colonic or skin defect models (oral + parenteral in animals)

• Vascular / Angiogenesis: VEGF-linked modulation; variable effects across models

• Inflammation: Pathway investigations in preclinical studies; reviews remain ongoing

For additional methodology, see the Mechanism Library.
(Frontiers +2 • PMC +2)

Technical Specifications

Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 aa)
Appearance: White/off-white (encapsulated powder)
Purity: ≥ 98% (HPLC verified) — COA Hub
Solubility: Water-soluble (research handling)
Storage: 2–8 °C recommended; protect from light & moisture (room temp short-term OK)
Traceability: Lot IDs linked to COA — COA Guide
(Frontiers)

Quality & Documentation

• Third-party testing (HPLC/MS as applicable)

• Batch-linked COA with identifiers — COA Hub

• Verification steps — COA Guide

• Safety Primer — Peptide Safety (checklist for research-only use)

BPC-157 vs TB-500 vs GHK-Cu — Quick Comparison

BPC-157 vs TB-500 (Thymosin β4):
Both appear in tissue-repair research. BPC-157 (15 aa) covers GI/tendon/muscle; TB-500 (43 aa Tβ4 fragment) emphasizes cell migration & wound repair.
See PMC reviews (2701135 | 8228050).
(PMC +1)

BPC-157 vs GHK-Cu:
BPC-157 = systemic/healing models vs GHK-Cu = skin remodeling/collagen research.
See PMC reviews (6073405 | 4508379).
(PMC +1)

For a full matrix, see Vendor & Peptide Comparison.

Research Peptide Comparison (Quick Reference)

Research Use Guidelines (Laboratory Only)

• Follow institutional biosafety and ethics policies

• Retain original container & labels for lot traceability

• Consult open-access PMC reviews (e.g., “BPC-157 tendon model”)

• Reference Peptide Safety for storage and verification steps
  (Frontiers)

FAQ — BPC-157 Capsules

Q1. What is BPC-157 used for in research?
A: Investigating tissue-repair biology, angiogenesis modulation, and GI/musculoskeletal healing in preclinical models. Frontiers Pharmacology 2021

Q2. Is BPC-157 orally bioavailable in studies?
A: Both oral and parenteral routes have been explored in animal work; human PK data are limited. (PMC reviews 2024–2025)

Q3. How does BPC-157 compare to TB-500?
A: BPC-157 (15 aa) = GI/tendon/ligament focus; TB-500 (43 aa) = migration and repair. (See PMC 2701135 | 8228050)

Q4. Do you provide COAs?
A: Yes — every batch includes a third-party COA: COA Hub | COA Guide

Q5. Is BPC-157 for human consumption?
A: No. Research-only; not for human or veterinary use.

Q6. Shipping & Returns?
A: See Shipping and Returns for carriers, cut-offs, and status notes.

<small>Last updated: October 17, 2025</small>

Selected Open-Access Reading (Neutral / Evidence-First)

• Frontiers Pharmacology (2021) — Stable Gastric Pentadecapeptide BPC-157 and Wound Healing (link)

• Scoping/Narrative Reviews (2024–2025) — Local & Systemic Peptide Therapies | Regeneration or Risk?

• Tendon Fibroblast Studies — Pentadecapeptide BPC-157 Enhances Growth of Tendon Fibroblasts

• Comparators: TB-500 (Thymosin β4) | GHK-Cu Reviews

All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Gentleman Peptide is a chemical supplier. Gentleman Peptide is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Gentleman Peptide is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Gentleman Peptide’s Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.

. .